Search Results | Cancer Research | American Association for Cancer Research

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Abstract 5714: Characterization of SWI/SNF complex gene mutations, protein expression and tumor immune microenvironment in cholangiocarcinoma

Clémence Astier, Jean-Yves Scoazec, Virginie Marty, Olivia Bawa, Nicolas Signolle, Carine Ngo, Francesco Facchinetti, Antoine Hollebecque, Sophie Postel-Vinay

Cancer Res (2022) 82 (12_Supplement): 5714.

DOI: https://doi.org/10.1158/1538-7445.AM2022-5714

Published: 15 June 2022

View article

Journal Articles

Abstract 1951: Circulating tumor cell-derived explant models reveal DNA damage response-based therapeutic opportunities in non-small cell lung cancer

Tala Tayoun, Vincent Faugeroux, Marianne Oulhen, Olivier Deas, Judith Michels, Laur Brulle-Soumare, Stefano Cairo, Jean-Yves Scoazec, Virginie Marty, Agathe Aberlenc, David Planchard, Jordi Remon, Santiago Ponce, Benjamin Besse, Patricia Kannouche, Jean-Gabriel Judde, Patrycja Pawlikowska, Françoise Farace

Cancer Res (2022) 82 (12_Supplement): 1951.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1951

Published: 15 June 2022

View article

Journal Articles

Abstract 595: Patterns and dynamics of genome instability drive metastatic activity in non-small cell lung cancer (NSCLC) circulating tumor cell (CTC)-derived xenograft (CDX) models

Tala Tayoun, Vincent Faugeroux, Marianne Oulhen, Emma Pailler, Olivier Deas, Laura Mezquita, Laura Brulle-Soumare, Stephano Cairo, Jean-Yves Scoazec, Virginie Marty, Agathe Aberlenc, Maud NgoCamus, Claudio Nicotra, David Planchard, Patricia Kannouche, Benjamin Besse, Jean-Gabriel Judde, Patrycja Pawlikowska, Françoise Farace

Cancer Res (2021) 81 (13_Supplement): 595.

DOI: https://doi.org/10.1158/1538-7445.AM2021-595

Published: 01 July 2021

View article

Journal Articles

Abstract 358: A prospective study of prostate cancer metastases identifies an androgen receptor activity-low, stemness program associated with resistance to androgen receptor axis inhibitors and unveils mechanisms of clonal evolution

Cancer Res (2021) 81 (13_Supplement): 358.

DOI: https://doi.org/10.1158/1538-7445.AM2021-358

Published: 01 July 2021

View article

Journal Articles

Abstract 448: High prevalence of pathogenic germline variants in patients with oncogene-driven non-small cell lung cancer

Cancer Res (2021) 81 (13_Supplement): 448.

DOI: https://doi.org/10.1158/1538-7445.AM2021-448

Published: 01 July 2021

View article

Journal Articles

Abstract 1114: Novel preclinical models of aggressive variants of castration-resistant prostate cancer

Cancer Res (2020) 80 (16_Supplement): 1114.

DOI: https://doi.org/10.1158/1538-7445.AM2020-1114

Published: 15 August 2020

View article

Journal Articles

Abstract 1867: Characterization of multiple driver alterations in acquired resistance to osimertinib in EGFR-mutated lung cancer: implementation of single cell approaches

Cancer Res (2020) 80 (16_Supplement): 1867.

DOI: https://doi.org/10.1158/1538-7445.AM2020-1867

Published: 15 August 2020

View article

Journal Articles

Abstract 2937: Preclinical evaluation of new therapeutic strategies on SDHB invalidated clones from human pheochromocytoma cells

Constance Lamy, Julien Hadoux, Sylvere Durand, Abir Alghuzlan, Julie Riviere, Deborah Lefevre, Amaury Bongers, Jean-Yves Scoazec, Eric Baudin, Angelo Paci, Sophie Broutin

Cancer Res (2019) 79 (13_Supplement): 2937.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2937

Published: 01 July 2019

View article

Journal Articles

Abstract 979: Programmed death-ligand 1 expression and tumor-infiltrating immune cells in cancers associated with Li-Fraumeni syndrome

Emilie Saucier, Claudia Pasqualini, Louise Galmiche, Frédérique Larousserie, Marie Karanian, Véronique Minard-Colin, Birgit Geoerger, Dominique Valteau-Couanet, Laurence Brugières, Jean-Yves Scoazec

Cancer Res (2019) 79 (13_Supplement): 979.

DOI: https://doi.org/10.1158/1538-7445.AM2019-979

Published: 01 July 2019

View article

Journal Articles

Abstract CT081: Pediatric precision medicine program in recurrent tumors: Results of the first 500 patients included in the European MAPPYACTS molecular profiling trial

Pablo Berlanga, Gudrun Schleiermacher, Ludovic Lacroix, Gaelle Pierron, Tiphaine Adam de Beaumais, Mathieu Chicard, Yasmine Iddir, Jean Yves Scoazec, Paul Freneaux, Mohamed Amine Bayar, Sophie Cotteret, Samuel Abbou, Michela Casanova, Cormac Owens, Stefan Michiels, Olivier Delattre, Gilles Vassal, Birgit Geoerger

Cancer Res (2019) 79 (13_Supplement): CT081.

DOI: https://doi.org/10.1158/1538-7445.AM2019-CT081

Published: 01 July 2019

View article

Journal Articles

Abstract 311: Diverse biological mechanisms drive resistance to Lorlatinib in ALK-rearranged Lung Cancer

Cancer Res (2019) 79 (13_Supplement): 311.

DOI: https://doi.org/10.1158/1538-7445.AM2019-311

Published: 01 July 2019

View article

Journal Articles

Abstract 318: Mechanisms of acquired resistance to FGFR inhibitors in molecularly-selected solid tumors: A prospective cohort from the MATCH-R study

Cancer Res (2019) 79 (13_Supplement): 318.

DOI: https://doi.org/10.1158/1538-7445.AM2019-318

Published: 01 July 2019

View article

Journal Articles

Abstract 2597: Development and characterization of novel non-small cell lung cancer (NSCLC) circulating tumor cells (CTCs)-derived xenograft (CDX) models

Vincent Faugeroux, Emma Pailler, Olivier Deas, Judith Michels, Laura Mezquita, Laura Brulle-Soumare, Stefano Cairo, Jean-Yves Scoazec, Virginie Marty, Pauline Queffelec, Maud Ngo-Camus, Claudio Nicotra, David Planchard, Patricia Kannouche, Benjamin Besse, Jean-Gabriel Judde, Françoise Farace

Cancer Res (2018) 78 (13_Supplement): 2597.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2597

Published: 01 July 2018

View article

Journal Articles

Abstract 5600: Establishment and characterization of a unique circulating tumor cells-derived xenograft (CDX) in prostate cancer

Vincent Faugeroux, Emma Pailler, Olivier Deas, Virginie Marty, Kamélia Alexandrova, Kiki Andree, Jean-Yves Scoazec, Nikolas Stoecklein, Nicolo Manaresi, Dominique Tramalloni, Maud Ngo-Camus, Claudio Nicotra, Leon Terstappen, Valérie Lapierre, Karim Fizazi, Yohann Loriot, Jean-Gabriel Judde, Françoise Farace

Cancer Res (2018) 78 (13_Supplement): 5600.

DOI: https://doi.org/10.1158/1538-7445.AM2018-5600

Published: 01 July 2018

View article

Journal Articles

Abstract CT004: European pediatric precision medicine program in recurrent tumors: first results from MAPPYACTS molecular profiling trial towards AcSe-ESMART proof-of-concept study

Birgit Geoerger, Gudrun Schleiermacher, Gaelle Pierron, Ludovic Lacroix, Marc Deloger, Nadia Bessoltane, Anne Catherine Harttrampf, Stefan Michiels, Jean Yves Scoazec, Paul Freneaux, Xavier Paoletti, Olivier Delattre, Natalie Hoog-Labouret, Gilles Vassal

Cancer Res (2017) 77 (13_Supplement): CT004.

DOI: https://doi.org/10.1158/1538-7445.AM2017-CT004

Published: 01 July 2017

View article

Journal Articles

Abstract 1011: RNAseq analysis obtained from on-purpose tumor biopsies of patients in the MATCH-R trial allows the identification of potential mechanisms of acquired resistance to PD(L)1 therapies

Cancer Res (2017) 77 (13_Supplement): 1011.

DOI: https://doi.org/10.1158/1538-7445.AM2017-1011

Published: 01 July 2017

View article

Journal Articles

The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

Renaud Grépin, Mélanie Guyot, Sandy Giuliano, Marina Boncompagni, Damien Ambrosetti, Emmanuel Chamorey, Jean-Yves Scoazec, Sylvie Negrier, Hélène Simonnet, Gilles Pagès

Cancer Res (2014) 74 (3): 873–883.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-1267

Published: 02 February 2014

View article

Includes: Supplementary data

Journal Articles

Abstract 3036: The dependence receptor TrkC is a putative colon cancer tumor suppressor.

Anne-Laure Genevois, Gabriel Ichim, Marie-May Coissieux, Marie-Pierre Lambert, Florian Lepinasse, Zdenko Herceg, Jean-Yves Scoazec, Servane Tauszig-Delamasure, Patrick Mehlen

Cancer Res (2013) 73 (8_Supplement): 3036.

DOI: https://doi.org/10.1158/1538-7445.AM2013-3036

Published: 15 April 2013

View article

Journal Articles

Abstract 28: The Netrin-1 receptor UNC5C is a tumor suppressor in colorectal malignancies

Marie-May Coissieux, Jerneja Tomsic, Christine Lasset, Heather Hampel, Jean-Yves Scoazec, Qing Wang, Stephan M. Tanner, Agnès Bernet, Albert de la Chapelle, Patrick Mehlen

Cancer Res (2012) 72 (8_Supplement): 28.

DOI: https://doi.org/10.1158/1538-7445.AM2012-28

Published: 15 April 2012

View article

Journal Articles

Abstract 4137: L-asparagine synthetase in solid tumors: Screening and implication in pancreatic cancer

Fabien Gay, Emmanuelle Dufour, Karine Aguera, Philip Lorenzi, Jean-Yves Scoazec, Françoise Horand, Yann Godfrin

Cancer Res (2011) 71 (8_Supplement): 4137.

DOI: https://doi.org/10.1158/1538-7445.AM2011-4137

Published: 15 April 2011

View article

NARROW

Abstract 5714: Characterization of SWI/SNF complex gene mutations, protein expression and tumor immune microenvironment in cholangiocarcinoma

Abstract 1951: Circulating tumor cell-derived explant models reveal DNA damage response-based therapeutic opportunities in non-small cell lung cancer

Abstract 595: Patterns and dynamics of genome instability drive metastatic activity in non-small cell lung cancer (NSCLC) circulating tumor cell (CTC)-derived xenograft (CDX) models

Abstract 358: A prospective study of prostate cancer metastases identifies an androgen receptor activity-low, stemness program associated with resistance to androgen receptor axis inhibitors and unveils mechanisms of clonal evolution

Abstract 448: High prevalence of pathogenic germline variants in patients with oncogene-driven non-small cell lung cancer

Abstract 1114: Novel preclinical models of aggressive variants of castration-resistant prostate cancer

Abstract 1867: Characterization of multiple driver alterations in acquired resistance to osimertinib in EGFR-mutated lung cancer: implementation of single cell approaches

Abstract 2937: Preclinical evaluation of new therapeutic strategies on SDHB invalidated clones from human pheochromocytoma cells

Abstract 979: Programmed death-ligand 1 expression and tumor-infiltrating immune cells in cancers associated with Li-Fraumeni syndrome

Abstract CT081: Pediatric precision medicine program in recurrent tumors: Results of the first 500 patients included in the European MAPPYACTS molecular profiling trial

Abstract 311: Diverse biological mechanisms drive resistance to Lorlatinib in ALK-rearranged Lung Cancer

Abstract 318: Mechanisms of acquired resistance to FGFR inhibitors in molecularly-selected solid tumors: A prospective cohort from the MATCH-R study

Abstract 2597: Development and characterization of novel non-small cell lung cancer (NSCLC) circulating tumor cells (CTCs)-derived xenograft (CDX) models

Abstract 5600: Establishment and characterization of a unique circulating tumor cells-derived xenograft (CDX) in prostate cancer

Abstract CT004: European pediatric precision medicine program in recurrent tumors: first results from MAPPYACTS molecular profiling trial towards AcSe-ESMART proof-of-concept study

Abstract 1011: RNAseq analysis obtained from on-purpose tumor biopsies of patients in the MATCH-R trial allows the identification of potential mechanisms of acquired resistance to PD(L)1 therapies

The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

Abstract 3036: The dependence receptor TrkC is a putative colon cancer tumor suppressor.

Abstract 28: The Netrin-1 receptor UNC5C is a tumor suppressor in colorectal malignancies

Abstract 4137: L-asparagine synthetase in solid tumors: Screening and implication in pancreatic cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only